EQ Latest Press Releases

-- October 26, 2026 --

Equillium Announces First Subject Dosed in Phase 1 Clinical Trial of EQ504 Globe Newswire 8:30 AM

-- October 6, 2026 --

Equillium Announces Poster Presentation at the 50th Anniversary La Jolla Immunology Conference Globe Newswire 4:05 PM

-- October 5, 2026 --

Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504 Globe Newswire 4:05 PM

-- September 29, 2026 --

Equillium Announces Poster Presentations at the 7th International AHR Conference Globe Newswire 4:05 PM

-- September 16, 2026 --

Equillium to Participate in Stifel's 2026 Virtual Immunology and Inflammation Forum Globe Newswire 8:30 AM

-- September 2, 2026 --

Equillium to Participate in Upcoming Investor Conferences Globe Newswire 8:30 AM

-- August 13, 2026 --

Equillium Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights Globe Newswire 4:05 PM

-- June 2, 2026 --

Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- May 28, 2026 --

Equillium to Participate in the 2026 Jefferies Global Healthcare Conference Globe Newswire 4:05 PM

Market Data Delayed 15 Minutes